Income · Stocks to Consider and Updates

Intel Delivers Strong Results; Improves Outlook

Chip giant Intel Corp. (NASDAQ: INTC - $56.15) reported strong results for the third quarter as sales came in at just under $19.2 billion, which was a shade higher than the previous year tally, but sharply above Street estimates of $18 billion. Adjusted earnings totaled $1.42 a share compared to $1.40 last year and markedly… Continue reading Intel Delivers Strong Results; Improves Outlook

Income · Stocks to Consider and Updates

Intel Acquires Pivot Technology’s Smart Edge Software Business

Santa Clara, California’s Intel Corp. (NASDAQ: INTC - $51.42) has agreed to purchase a software business from Toronto-based Pivot Technology Solutions Inc. for $27 million in cash. Intel said it would purchase Smart Edge, a software business that is designed to help split up data and store it closer to users to make computing devices respond… Continue reading Intel Acquires Pivot Technology’s Smart Edge Software Business

Income · Stocks to Consider and Updates

Johnson & Johnson Beats Street Views; Hikes Outlook

Health care products giant Johnson & Johnson (NYSE: JNJ - $133.41) reported third-quarter financial results that were better than expected. For the period, J&J came in with adjusted earnings of $2.12 per share vs. $2.05 last year and eleven cents ahead of Street estimates. The top line increased 1.9% over the year-earlier third quarter to… Continue reading Johnson & Johnson Beats Street Views; Hikes Outlook

Income · Stocks to Consider and Updates

Cisco Reports In-line; Outlook Disappoints

Networking equipment and software provider Cisco Systems, Inc. (NASDAQ : CSCO  -$46.55) reported in-line results for the fiscal fourth quarter. However, guidance was below expectations and the shares are down about 8% in response. Total revenue of $13.4 billion matched Street estimates and grew 6% year-over-year, with around 10% of the advance coming from acquisitions.… Continue reading Cisco Reports In-line; Outlook Disappoints

Income · Stocks to Consider and Updates

Income Portfolio – Allocation Update

I am making a few allocation changes to the income portfolio. I am increasing the share of the pie for CVS Health as they may be finally turning the corner and the shares are highly undervalued. CVS is bumped from 6% to 8%. Conversely, the cyclical nature of the chemical industry is taking its toll… Continue reading Income Portfolio – Allocation Update

Income · Stocks to Consider and Updates

CVS Posts Strong Results; Improves Guidance

Health care services provider CVS Health Corp. (NYSE: CVS - $57.34) reported adjusted earnings per share of $1.89, beating both last year’s results and Wall Street consensus estimates of $1.69. Total revenue was $63.4 billion, which included revenue from Aetna and not comparable to last year’s figure, but higher than Street estimates of $62.63 billion.… Continue reading CVS Posts Strong Results; Improves Guidance

Income · Stocks to Consider and Updates

LyondellBasell Misses Estimates; Hikes Dividend

Shares of chemicals major LyondellBasell Industries N.V. (NYSE: LYB - $77.65) are retreating about 5% after reporting second quarter earnings per share of $2.70, down from $4.22 a year ago and missing the $2.83 average estimate from analysts. Sales fell to $9.05 billion from $10.21 billion a year earlier, also short of the $9.61 billion… Continue reading LyondellBasell Misses Estimates; Hikes Dividend